Browse our anti-phosphodiesterase 5A, CGMP-Specific (PDE5A) Antibodies

Full name:
anti-phosphodiesterase 5A, CGMP-Specific Antibodies (PDE5A)
On are 39 phosphodiesterase 5A, CGMP-Specific (PDE5A) Antibodies from 16 different suppliers available. Additionally we are shipping phosphodiesterase 5A, CGMP-Specific Kits (18) and phosphodiesterase 5A, CGMP-Specific Proteins (7) and many more products for this protein. A total of 71 phosphodiesterase 5A, CGMP-Specific products are currently listed.
CGB-PDE, Cgbpde, CN5A, Cn5n, Pde5, pde5a, Pde5a1, PDE5A2
list all antibodies Gene Name GeneID UniProt
PDE5A 8654 O76074
PDE5A 242202 Q8CG03
PDE5A 171115 O54735

Show all species

Show all synonyms

Most Popular Reactivities for anti-phosphodiesterase 5A, CGMP-Specific (PDE5A) Antibodies

Select your species and application

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-phosphodiesterase 5A, CGMP-Specific Antibodies

Go to our pre-filtered search.

Top referenced anti-phosphodiesterase 5A, CGMP-Specific Antibodies

  1. Human Polyclonal PDE5A Primary Antibody for IP, WB - ABIN493302 : Lin, Xin, Lin, Lue: Phosphodiesterases as therapeutic targets. in Urology 2003 (PubMed)
    Show all 3 references for 493302

  2. Rat (Rattus) Monoclonal PDE5A Primary Antibody for IF, WB - ABIN968563 : Corbin, Francis: Cyclic GMP phosphodiesterase-5: target of sildenafil. in The Journal of biological chemistry 1999 (PubMed)
    Show all 3 references for 968563

  3. Human Polyclonal PDE5A Primary Antibody for IP, WB - ABIN493300 : Rybalkin, Rybalkina, Feil, Hofmann, Beavo: Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells. in The Journal of biological chemistry 2002 (PubMed)
    Show all 3 references for 493300

  4. Human Polyclonal PDE5A Primary Antibody for ELISA, WB - ABIN185350 : Morelli, Filippi, Mancina, Luconi, Vignozzi, Marini, Orlando, Vannelli, Aversa, Natali, Forti, Giorgi, Jannini, Ledda, Maggi: Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. in Endocrinology 2004 (PubMed)

  5. Human Monoclonal PDE5A Primary Antibody for IF, ELISA - ABIN563735 : Maharaj, OToole, Lynch, Carney, Jarman, Higgins, Morrison, Laffey: Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. in Reproductive biology and endocrinology : RB&E 2009 (PubMed)

  6. Cow (Bovine) Polyclonal PDE5A Primary Antibody for IHC, WB - ABIN2789423 : Ioki, Wu, Takayama, Motohashi, Wakai, Funahashi: A phosphodiesterase type-5 inhibitor, sildenafil, induces sperm capacitation and penetration into porcine oocytes in a chemically defined medium. in Theriogenology 2016 (PubMed)

More Antibodies against phosphodiesterase 5A, CGMP-Specific Interaction Partners

Cow (Bovine) phosphodiesterase 5A, CGMP-Specific (PDE5A) interaction partners

Human phosphodiesterase 5A, CGMP-Specific (PDE5A) interaction partners

  1. Data indicate that high type 5 phosphodiesterase (PDE5) expression in glioblastoma multiforme (GBM) cells significantly correlated with longer overall survival of patients.

  2. the relationship between PDE5A polymorphisms, diabetes, and the efficacy of sildenafil treatment.The response to sildenafil treatment depends on polymorphisms in the PDE5A gene and the glycemic status of the patients.

  3. Study showed that past attempts to quantify PDE5 mRNA were flawed due to the use of incorrect primers, and that when correct primers are used, PDE5 mRNA is detectable in human brain tissue; that PDE5 protein exists in human brain by western blot and ELISA; and performed immunohistochemistry and demonstrate that PDE5 is present in human neurons.

  4. Our data showed a significant and previously undocumented upregulation of PDE5 in both rat and human BPH (show GLI3 Antibodies).

  5. Overexpression of PDE5 in papillary thyroid carcinomas.

  6. cGMP PDE (show ALDH7A1 Antibodies) isozymes, PDE5 and 10, are elevated in colon tumor cells compared with normal colonocytes, and inhibitors and siRNAs can selectively suppress colon tumor cell growth

  7. Results show that Ser102 and Ser104 may influence the conformational flexibility of PDE5A, which may in turn influence phosphorylation status, allosteric regulation by cGMP or other as yet unknown regulatory mechanisms for PDE5A.

  8. PDE5A appears to jointly influence amygdala volume and emotion recognition performance.

  9. inhibition of PDE5 can counteract apoptosis during aging by modulating proand antiapoptotic molecules and the APP (show APP Antibodies) pathway.

  10. Myocardial PDE5 expression is increased in the hearts of humans and mice with chronic pressure overload.

Mouse (Murine) phosphodiesterase 5A, CGMP-Specific (PDE5A) interaction partners

  1. Upon S-nitrosylation, PDE5 exhibits reduced activity and degradation via the ubiquitin-proteasome system.

  2. Short-term hemolysis is sufficient to establish a priapism phenotype and results in loss of erectile function. PDE5I treatment ameliorates priapism, in part, because of restored NO balance with decreased ROS (show ROS1 Antibodies) generation and increased PDE5 activity.

  3. Addition of sildenafil, a phosphodiesterase 5 (PDE5) inhibitor, in the drinking water had a small effect in reducing myocyte hypertrophy in wild type mice and no effect in betaRM mice.

  4. findings reveal that excess adenosine-mediated ADORA2B (show ADORA2B Antibodies) signaling underlies reduced penile PDE (show TWIST1 Antibodies) activity by decreasing PDE5 gene expression in a HIF-1alpha (show HIF1A Antibodies)-dependent manner

  5. Findings suggest that continuous, long-term treatment with PDE5 inhibitors reverses eNOS (show NOS3 Antibodies) uncoupling in the sickle cell penis which restores endothelial NO synthesis.

  6. Data indicate that the phosphodiesterase 5 (PDE5) expression is equal in the splenocytes from both genders, but splenocytes from female mice possess higher basal level of cGMP compared to the male ones.

  7. Myocardial PDE5 expression is increased in the hearts of humans and mice with chronic pressure overload.

  8. PDE5 inhibition did not alter atrial natriuretic peptide (show NPPA Antibodies)-stimulated cGMP in the resting heart but augmented it in the transaortic constriction heart.

  9. Sildenafil-mediated PDE5 inhibition significantly reduces diaphragm respiratory muscle dysfunction and pathology in the mdx (show DMD Antibodies) mouse model of Duchenne muscular dystrophy (show DMD Antibodies).

  10. these data strongly support a primary role of myocyte PDE5 regulation to myocardial pathobiology

Pig (Porcine) phosphodiesterase 5A, CGMP-Specific (PDE5A) interaction partners

  1. PDE5 inhibition and increase in cGMP produce pulmonary vasodilation that is mediated in part through inhibition of the ET pathway, thereby precluding an additional vasodilator effect of ETA/ETB (show EDNRB Antibodies) receptor blockade in the presence of PDE5 inhibition.

  2. PDE5 is a key regulator of NO-induced vasodilation in the postnatal pulmonary arteries.

phosphodiesterase 5A, CGMP-Specific (PDE5A) Antigen Profile

Antigen Summary

This gene encodes a cGMP-binding, cGMP-specific phosphodiesterase, a member of the cyclic nucleotide phosphodiesterase family. This phosphodiesterase specifically hydrolyzes cGMP to 5'-GMP. It is involved in the regulation of intracellular concentrations of cyclic nucleotides and is important for smooth muscle relaxation in the cardiovascular system. Alternative splicing of this gene results in three transcript variants encoding distinct isoforms.

Alternative names and synonyms associated with phosphodiesterase 5A, CGMP-Specific (PDE5A)

  • phosphodiesterase 5A, cGMP-specific (PDE5A) antibody
  • phosphodiesterase 5a, cGMP-specific (pde5a) antibody
  • phosphodiesterase 5A, cGMP-specific, b (pde5ab) antibody
  • phosphodiesterase 5A, cGMP-specific (pde5a) antibody
  • phosphodiesterase 5A, cGMP-specific (Pde5a) antibody
  • phosphodiesterase isozyme 5 (PDE5) antibody
  • CGB-PDE antibody
  • Cgbpde antibody
  • CN5A antibody
  • Cn5n antibody
  • Pde5 antibody
  • pde5a antibody
  • Pde5a1 antibody
  • PDE5A2 antibody

Protein level used designations for PDE5A

CGB-PDE , cGMP-binding cGMP-specific phosphodiesterase , cGMP-specific 3',5'-cyclic phosphodiesterase , phosphodiesterase 5A, cGMP-specific , phosphodiesterase 5a, cGMP-specific , phosphodiesterase 5a , cGMP-specific 3',5'-cyclic phosphodiesterase-like , cGMP-binding cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase , cGMP-specific phosphodiesterase PDE5A2 , cGMP-specific phosphodiesterase type 5A , phosphodiesterase isozyme 5 , cGMP-binding/cGMP-specific phosphodiesterase , cGMP-binding cGMP specific phosphodiesterase 5A2 , phosphodiesterase type 5 , 3',5'-Cyclic GMP Phosphodiesterase , cyclic nucleotide phosphodiesterase 5a

100072395 Equus caballus
281972 Bos taurus
461461 Pan troglodytes
495103 Xenopus laevis
553270 Danio rerio
705592 Macaca mulatta
780273 Xenopus (Silurana) tropicalis
100391416 Callithrix jacchus
100446315 Pongo abelii
100482637 Ailuropoda melanoleuca
100495581 Xenopus (Silurana) tropicalis
100533976 Felis catus
100539087 Meleagris gallopavo
100560459 Anolis carolinensis
100581952 Nomascus leucogenys
8654 Homo sapiens
242202 Mus musculus
171115 Rattus norvegicus
403825 Canis lupus familiaris
785098 Bos taurus
422677 Gallus gallus
100527958 Cavia porcellus
397616 Sus scrofa
Selected quality suppliers for anti-phosphodiesterase 5A, CGMP-Specific (PDE5A) Antibodies
Did you look for something else?